In developing mammals, we and others demonstrated that sulfation is an impo
rtant pathway in the metabolism of thyroid hormone, and there is significan
t fetal-maternal transfer of sulfated iodothyronine. In the present study,
we characterized a novel iodothyronine sulfotransferase (IST) in pregnant r
at uterus. I-125-labeled 3,3'-diiodothyronine (T-2), T-3, rT(3), and T-4 we
re used as substrates with unlabeled 3'-phosphoadenosine-5'-phosphosulfate
(PAPS) as the sulfate donor. Sulfated iodothyronine products were separated
by Sephadex LH-20 column and further identified on reverse phase HPLC. We
measured IST activity in pregnant rat uterus by incubating 1 muM substrate,
50 muM PAPS, and 50 mug cytosol protein, pH 7.2, 30 min at 37 degreesC. Th
e results show that the substrate preference of the uterine IST activity is
: T-2 > rT(3) > T-3 > T-4; the pH optimum is 6.0 for T-2. The K-m and V-max
(for gestational day 21 uterus) for T-2 are 0.62 muM and 3466 pmol/mg prot
ein/h, respectively; for PAPS the values are 2.6 muM and 1523 pmol/mg pmtei
n/h, respectively. During pregnancy, the total activities exhibit a U-shape
d curve with minimum activity at day 13 of gestation; while a thermostable
activity increases significantly near term. In summary, there is significan
t uterine IST that varies during pregnancy. The role of this uterine sulfot
ransferase activities in regulating the bioavailability of thyroid hormone
in the developing fetus remains to be elucidated.